Corporate Breaking News
Corporate Breaking News
Home : PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period
Jan 22
2020

PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period

MADRID and DUBLIN, Jan. 22, 2020 /PRNewswire/ -- PharmaMar (MSE:PHM) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announce that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended "HSR", with respect to the exclusive license agreement for...
Source:https://www.prnewswire.com:443/news-releases/pharmamar-and-jazz-pharmaceuticals-announce-the-us-license-agreement-for-lurbinectedin-is-effective-with-the-expiration-of-the-hsr-waiting-period-300990912.html
 
Related News
» Dutch Hospital Expands its Use of Sectra's Medical Imaging Solution to Include Digital Pathology
» Expert Evaluation Clarifies Phase 3 Results and Provides Strong Support for MOB-015
Home
About us
Archive
Sitemap
Powered By Corporate Breaking News.com Home| About us| Archive News| Sitemap